Check if you qualify
Take a short quiz to see if you may be a candidate for Eversense 365.
Expert guidance. Every step of the way.
Getting started with Eversense 365 takes a few simple steps. Rest assured—we have experts on hand to guide you through each one of them.
One Brief Office Visit Per Year
One brief office visit per year to place your Eversense 365 sensor gets you a full year of real time glucose readings.
Quick, Simple Process
Sensor placement and removal is normally quick, with only a small incision - involving no stitches and only a bandage!
Connect with an Eversense Expert
An Eversense Expert will contact you to answer your questions, confirm eligibility, and locate a nearby Eversense Inserter. If interested, we’ll work directly with your healthcare provider and a distribution partner to submit to your insurance provider and order your Eversense 365 CGM.
Sensor Placement
Once approved, we’ll ship your Eversense 365 to a nearby Inserter, who will get you started on Eversense 365 via a quick and simple in-office procedure that you schedule.
That’s It!
We’ll also provide tools and support to help you get the most out of your daily life with Eversense 365.
See why people are choosing
Eversense.
Learn more about the experiences of Eversense users whose lives were changed after switching to a long-term CGM.
Want to see if you
qualify?
Our short quiz will ask about your insurance coverage, your insulin usage, and what benefits you’re looking for in a CGM.
If you’re ready, click below and let’s see if Eversense 365 is right for you.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
PP-SENS-E3-GBL-0047